Underuse of radiotherapy in lung cancer negatively impacts survival  by Expósito, J. et al.
reports of practical oncology and radiotherapy 1 8 ( 2 0 1 3 ) S259–S274 S273
Method. Between 2009 and 2012, 110 patients with localized NSCLC had radical 3-dimensional conformal radiotherapy (3D-CRT).
63% of patients received concomitant chemotherapy. The acute toxicity was evaluated retrospectively according to Common
Terminology Criteria Adverse Events V3.0. Analysis was conducted for the maximum
Results. 6% of patients developed acute grade 3 esophagitis. 34% of patients developed acute grade 2 esophagitis. No grade 3 or
4 acute esophagitis was seen in patients without concomitant chemotherapy or with involved ﬁeld irradiation. On univariate
analysis acute grade 2 and 3 esophagitiswas higher in patientwith concomitant chemotherapy (p<0.05). Severe acute esophagitis
was lower in patient with involved ﬁeld irradiation (IFI) (p<0.05).
Conclusions. Higher risk of grade ≥2 treatment-related esophagitis was associated with use of concomitant chemotherapy and
with lower total esophageal volume dose. IFI decreases sever acute esophagitis in patients with NSCLC.
http://dx.doi.org/10.1016/j.rpor.2013.03.328
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Introduction. Lung cancer is the ﬁrst cause of death due to cancer in males and the third in females. RT alone or with others
therapies has proven to be an effective treatment. However, underuse of radiotherapy has been observed in various studies.
Objective: To assess the use of radiotherapy as initial treatment for lung cancer in Andalusia, a southern region of Europe.
Methods. A systematic review of the literature and clinical practice guidelines for lung cancer was performed to estimate expected
radiation rates and the beneﬁt from this treatment. We then collected data from the clinical and treatment records of all patients
undergoing radiotherapy for lung cancer during 2007 in all the 12 public hospitals in Andalusia which possessed RT Services.
Results. In 2007, it was estimated 3051 incident cases of lung cancer, but only 610 patients underwent initial radiotherapy for
lung cancer. Thus, the overall radiation rate was 20%, and signiﬁcantly differed among provinces (range, 8.5–25.6%, p<0.001).
According to the expected radiation rate (1383 patients), 773 more patients of lung cancer (25%) should have been treated. The
maximum increased survival attributable to the use of radiotherapy in patients with non–small-cell lung cancer ranges from 1.8
to 14.1 months, depending on the reviewed article. In this way, the underuse estimated in the region would correspond to a loss
of more than 3000 months in survival time.
Conclusions. The observed underuse has an important negative impact on patients measured in the months of survival.
http://dx.doi.org/10.1016/j.rpor.2013.03.329
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Introduction. The use of 4D-CT has introduced the possibility of measuring internal movements in lung treatments. Our objective
is to determine what are these movements for a group of 10 patients, not necessarily with lung cancer, and determine which
anatomical area has displacements less than 5mm, so that they are suitable to be located with megavoltage CBCT, and be treated
without tracking or gating techniques nor any breath holding devices.
Methods. We used a Siemens Somaton Sensation Open Bore CT, with pressure belt-based respiratory phase acquisition device
(Anzai). For each patient a 4D acquisition along the entire length of the thorax was acquired. 10 phases were reconstructed (5
inspiration/5 exhalation) and transferred to a 4D analysis workstation (InSpace, Siemens), where the bronchial movements were
measured in cartesian directions.
Results. Result show that there is a motility that depends on the distance of the bronchus from the lung apex and the diaphragm.
For our population, in the upper third of the lung at 4 cm from apex the maximum movement was less than 5mm (3mm average).
At 7 cm the maximum movement was less than 10mm (6mm average). On the other hand, near diaphragm (20 cm from apex)
maximum elongation was 36mm (18mm average).
Conclusions. Upper lung lobe treatment delivery can be performed with proper daily CBCT localization techniques. Tracking or
gating techniques thus can be ignored for lesions located near apex and with use of conventional 3D margins. Nevertheless, 4D
individual patient study is required and yet caution must be taken about the eventual migration of the lesion from reference CT
position.
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